Sei Medical Public Co., Ltd. · SET:SEI
Sei Medical Public — Q1 2026 Earnings Presentation
20 slides from Sei Medical Public's earnings presentation, May 19, 2026
Slide 1: Earnings Call (OPPDAY)
Earnings Call (OPPDAY) SEI Medical Public Company Limited Tuesday May 19, 2026, at 10:30 AM
Slide 2: Today's Agenda
TODAY’S AGENDA 01 Company & Business Overview 02 Q1/2026 Financial Highlights 03 Root Cause Analysis & Strategic Alignment 04 Strategic Growth & Market Opportunities 05 Q&A Session
Slide 3: Company & Business Overview
SEI Medical Public Company Limited or “SEI” “Company & Business Overview”
Slide 4: SEI Medical Public Company Limited
Company & Business Overview SEI Medical Pubic Company Limited A leading distributor and service provider of a wide range of medical devices, disposable medical supplies, and scientific instruments in Thailand, serving hospitals, clinics, and research institutions. Ticker Initial Public Offering (IPO
Slide 5: Since Your Day One: 8 Product Groups
Company & Business Overview Business Units 25 Brands “SINCE YOUR DAY ONE” 8 Product Groups Covering all Stages of Life Neonatal Care Endoscope 1,000+ Products Surgery Laboratory Aesthetic Intensive Care Unit (ICU) Medical Imaging Solutions (2026) Urology (2026)
Slide 6: New Growth Engines - Medical Imaging & Urology
Company & Business Overview Business Units New Growth Engines - Medical Imaging & Urology FUJIFLIM I Medical Imaging Solution DORNIER I Thulio Urology WHY This Market? WHY This Market? Thailand’s aging population creates structural demand for BPH and AI-power ultrasound demand is surging across Thai
Slide 7: Q1/2026 Financial Highlights
SEI Medical Public Company Limited or “SEI” “Q1/2026 Financial Highlights”
Slide 8: Financial Performance: Total, Product and Service Revenue
Q1/2026 Financial Highlights Financial Performance Total Revenue Product Sales Revenue Service Revenue Revenue from sales of goods (THB million) (THB million) (THB million) Revenue from rendering services 200 140 133.56 14 13.55 147.11 48.25 120 12 10.60 150 100 10 31 13.55 89.61 .8 8% 100.21 Yo 80
Slide 9: Gross Profit and Net Profit Margins
Q1/2026Financial Highlights Financial Performance Gross Profit and GPM Net Profit and NPM (THB million) (THB million) 60 25 22.18 50.43 50 20 NPM = 15.1% 40 38.54 GPM = 34.3% GPM = 38.5% 15 30 10 20 7.77 5 NPM = 7.8% 10 0 0 Q1/2025 Q1/2026 Q1/2025 Q1/2026 -23.58% YoY (-11.89M) -64.97% YoY (-14.41M)
Slide 10: Cost Breakdown Comparison
Q1/2026 Financial Highlights Financial Performance Cost Breakdown Comparison Stable Gross Profit Margin 37.67% maintained despite cost pressures Q1/2025 Effective product mix management (THB million) Q1/2026 Higher S&D Costs 100 +48.67% YoY investment 86.93 Reflects investment in new product expansi
Slide 11: Financial Position
Q1/2026 Highlights Financial Performance Financial Position Asset Liabilities and Equity Liabilities (THB million) (THB million) Equity 600 600 500 500 514.99 519.98 312.01 319.78 400 400 300 300 200 200 202.98 200.20 100 100 0 0 EY2025 Q1/2026 EY2025 Q1/2026
Slide 12: Q1/2026 Highlights
2026 Highlights Q1/2026 HIGHLIGHTS INVESTMENT 100.2 MB 38.5% 7.8 MB YEAR -31.9% YoY Gross Profit Margin Net Profit Net Profit Decline Reflects Revenue Stability Achieved Despite Deliberate investment in Sales, New Political Instability Products, and Market Expansion
Slide 13: Root Cause Analysis & Strategic Alignment
SEI Medical Public Company Limited or “SEI” “Root Cause Analysis & Strategic Alignment”
Slide 14: Root Cause Analysis
Root Cause Analysis & Strategic Alignment Political Uncertainty & Government Procurement Deferral Post-election budget sequencing procurement delays that extended into early 2026. Geopolitical conflicts between the U.S. and Iran invariably Root Cause trigger a costly domino effect across the global
Slide 15: Strategic Alignment
Root Cause Analysis & Strategic Alignment Strategic Alignment Key Learnings 70% With 70% of our customer base in the public sector, over-reliance on government budgets is a recognized risk Expanding our Expanding the Exploring B2C consumable private hospital and product categories portfolio clinic s
Slide 16: Q2 Outlook
Root Cause Analysis & Strategic Alignment Q2 Outlook Expected project signing Gross Profit Margin 140 MB >35% Service Revenue New Opportunities 10 MB Product Lines JV and M&A
Slide 17: 2026 Outlook & Strategy
SEI Medical Public Company Limited or “SEI” “2026 Outlook & Strategy”
Slide 18: Strategic Initiatives
2026 Outlook and Strategy Strategic Initiatives JV & +20 +28 Revenue from Service +30 Net Profit (%) NEW Product Line M&A New Opportunities Total Revenue (%) Stream 449.7M 62M 46.5M in Related Business 2026 Full-Year Target 2026 Full-Year Target 2026 Full-Year Target Recovery Pathway - Q2 to Q4 2026
Slide 19: Joint Venture - Merge and Acquisition
2026 Outlook and Strategy Strategic Initiatives: Joint Venture - Merge and Acquisition Neonatal Care 01 Access new technology faster Endoscope Surgery 02 Shared Distribution Networks Laboratory 03 Lower Capital Risk Aesthetic Joint Venture 04 Instant Portfolio Expansion Intensive Care Unit Merge and
Slide 20: Since You Day One...
“SINCE YOU DAY ONE...”
SEI Medical Public Company — Q1 2026 Earnings Presentation on 6ix